Bourne in his new role will be responsible for R&D, sustaining engineering, operations and clinical affairs, succeeding former senior VP of global operations Scott Etlinger.
"George Bourne has quickly made a very positive contribution to AngioDynamics since joining our team earlier this year," president & CEO Joseph DeVivo said in prepared remarks. "George’s deep commitment to operational excellence, combined with more than 25 years of experience in operations and R&D at global medical device companies, provide us with a very capable and seasoned executive to lead our R&D and operations teams as we implement our growth strategies."
FCC searches for a healthcare leader
The FCC hopes to hire a director of healthcare Initiatives, who will serve for a maximum of 4 years at an annual compensation of between $123,758 and $155,500.
The position is responsible for providing guidance to the team, overhauling the $400 million Rural Health Care program and working with government bodies or private sectors, the job posting noted.
Avedro adds science fellow
Waltham, Mass.-based company Avedro named Satish Herekar to be its new science fellow.
He will be responsible for Avedro’s trans-epithelial cross-linking research and innovation.
Herekar was co-founder of Seros Medical. He also worked at Sunrise Technologies, Sepragen, Acuson, Cooper Vision, and General Electric.
LeMaitre Vascular shuffles its board of directors
Michael Jackson, William Thorndike, Jr. and Dr. George LeMaitre resigned from the LeMaitre Vascular’s board of directors, effective December 6.
The company named Thorndike, Jr. as a director of the company and chairman of the nominating and corporate governance committee of the board, effective December 9.
Premier names chief sales officer
Premier healthcare alliance named Gary Long as the company’s chief sales officer, effective immediately.
Long most recently was senior vice president of sales and support for Surgical Information Systems. He also worked at McKesson Technology Solutions, Dornier Medical Systems and other organizations in sales, marketing and operations.
Greatbatch has new board director
Greatbatch (NYSE:GB) appointed Rudy Mazzocchi to its board of directors. Mazzocchi will be on the board’s technology development & innovation and corporate governance & nominating committees.
Mazzocchi is currently CEO of Elenza, prior to which, he worked at NoraVision, Accuitive Medical Ventures, Microvena Corporation and Cook Critical Care.
The device maker named Michael Eagle the chairman of the board and Dr. Stephen Newman chairman of the nominating & corporate governance committee.
Dr. Gershman is one of the 1st surgeons in the world to apply the method of laparoscopic surgery and robotic-assisted surgery to urology. He currently holds numerous hospital appointments.